Dr. Reddy's Laboratories Ltd Common Stock (RDY)
EBITDA Margin
18.37%
TTM · Period ending:
RDY EBITDA Margin
Latest reported18.37%period ending
Latest reported18.37%period ending
RDY TTM EBITDA Margin (36.16% → 18.37%)
TTM ebitda margin
High-resolution chart · PNG
RDY ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 18.367% | |
| 22.9693% | |
| 27.1624% | |
| 28.7866% | |
| 29.3436% | |
| 29.2439% | |
| 28.9931% | |
| 29.4794% | |
| 31.0715% | |
| 32.1861% | |
| 36.1417% | |
| 35.5722% | |
| 35.0751% | |
| 36.8756% | |
| 36.5922% | |
| 34.8816% | |
| 34.7228% | |
| 28.4651% | |
| 25.7265% | |
| 25.2396% | |
| 25.5037% | |
| 28.5835% | |
| 26.9404% | |
| 32.1933% | |
| 26.8504% | |
| 27.8089% | |
| 27.2301% | |
| 24.7029% | |
| 24.8041% | |
| 22.3183% | |
| 21.1603% | |
| 20.449% | |
| 19.266% | |
| 16.6474% | |
| 17.2169% | |
| 17.8041% | |
| 17.3955% | |
| 17.9371% | |
| 18.9555% | |
| 19.6421% | |
| 22.7811% | |
| 25.9741% | |
| 25.7863% | |
| 25.4201% | |
| 23.9083% | |
| 23.2042% | |
| 23.5089% | |
| 24.4786% | |
| 25.0574% | |
| 24.5235% | |
| 24.4704% | |
| 22.8394% | |
| 22.0143% | |
| 21.9944% | |
| 20.4121% | |
| 23.4554% | |
| 23.5268% | |
| 23.7675% | |
| 26.2394% | |
| 22.4837% | |
| 22.4882% | |
| 22.6969% | |
| 21.4299% | |
| 9.1518% | |
| 8.4782% | |
| 9.3659% | |
| -6.655% | |
| 6.309% | |
| 5.1463% | |
| 2.3944% | |
| 19.5056% | |
| 16.3541% | |
| 16.9129% | |
| 18.3782% | |
| 21.3908% | |
| 22.0142% | |
| 22.6475% | |
| 21.8737% | |
| 18.1259% | |
| 16.9678% | |
| 13.3959% | |
| 9.9781% | |
| 7.3107% | |
| 5.832% | |
| 4.8142% | |
| 3.7156% | |
| 8.0679% | |
| 11.4278% | |
| 13.5805% | |
| 17.6129% | |
| 20.5443% | |
| 21.5413% | |
| 21.6795% | |
| 24.1427% | |
| 26.1588% | |
| 30.4264% | |
| 37.2181% | |
| 36.1572% |